Get the Stockscreener App
0.69
5.12%
0.0336
After Hours:
.68
-0.010
-1.45%
VolitionRX Ltd stock is traded at $0.69, with a volume of 104.33K.
It is up +5.12% in the last 24 hours and down -2.47% over the past month.
VolitionRX Limited, a life sciences company, engages in the development of blood tests to help diagnose a range of cancers worldwide. The company develops 39 epigenetic Nu.Q blood assays based on its Nucleosomics biomarker discovery platform. VolitionRX Limited is based in Singapore.
See More
Previous Close:
$0.6564
Open:
$0.655
24h Volume:
104.33K
Relative Volume:
0.49
Market Cap:
$74.24M
Revenue:
$1.29M
Net Income/Loss:
$-29.87M
P/E Ratio:
-1.9167
EPS:
-0.36
Net Cash Flow:
$-14.70M
1W Performance:
+0.29%
1M Performance:
-2.47%
6M Performance:
+7.95%
1Y Performance:
+1.97%
1-Day Range:
$0.64
$0.69
1-Week Range:
$0.64
$0.7078
52-Week Range:
$0.3951
$0.94
VolitionRX Ltd Stock (VNRX) Company Profile
Name
VolitionRX Ltd
Sector
Industry
Phone
646 650 1351
Address
No. 24-05 Shaw Centre, 1 Scotts Road, Singapore, TX
Compare VNRX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
VNRX
VolitionRX Ltd
|
0.69 | 70.63M | 1.29M | -29.87M | -14.70M | -0.36 |
|
TMO
Thermo Fisher Scientific Inc
|
492.72 | 184.93B | 43.21B | 6.58B | 6.17B | 17.29 |
|
DHR
Danaher Corp
|
205.82 | 147.00B | 24.01B | 3.41B | 4.86B | 4.70 |
|
IDXX
Idexx Laboratories Inc
|
647.09 | 51.77B | 4.04B | 985.66M | 774.34M | 12.01 |
|
A
Agilent Technologies Inc
|
125.66 | 35.50B | 6.63B | 1.17B | 1.19B | 4.05 |
|
IQV
Iqvia Holdings Inc
|
190.81 | 32.08B | 15.70B | 1.24B | 2.01B | 6.91 |
VolitionRX Ltd Stock (VNRX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-08-25 | Initiated | H.C. Wainwright | Buy |
| Feb-01-23 | Downgrade | The Benchmark Company | Buy → Hold |
| Feb-17-22 | Resumed | Cantor Fitzgerald | Overweight |
| Mar-10-21 | Initiated | Cantor Fitzgerald | Overweight |
| May-16-18 | Initiated | Maxim Group | Buy |
| May-14-18 | Reiterated | The Benchmark Company | Buy |
| Sep-07-16 | Reiterated | Rodman & Renshaw | Buy |
| Feb-01-16 | Initiated | Rodman & Renshaw | Buy |
View All
VolitionRX Ltd Stock (VNRX) Latest News
How to forecast VolitionRx Limited trends using time series2025 Technical Patterns & Risk Controlled Swing Alerts - Newser
VolitionRx : Corporate Presentation September 2025 - MarketScreener
Developing predictive dashboards with VolitionRx Limited dataTrade Exit Summary & High Accuracy Trade Alerts - Newser
VolitionRx Ltd. Earnings Call: Key Insights and Challenges - TipRanks
Using AI based signals to follow VolitionRx Limited2025 Major Catalysts & High Conviction Trade Alerts - Newser
VolitionRx Limited stock prediction for this weekTrade Ideas & Capital Efficient Trading Techniques - Newser
Trend analysis for VolitionRx Limited this weekWeekly Market Outlook & Weekly Market Pulse Updates - Newser
Price momentum metrics for VolitionRx Limited explainedJuly 2025 Opening Moves & Fast Gaining Stock Reports - Newser
What earnings revisions data tells us about VolitionRx LimitedTrade Volume Report & Real-Time Volume Trigger Notifications - Newser
What to do if you’re stuck in VolitionRx LimitedMarket Performance Report & Stock Portfolio Risk Control - Newser
Tools to monitor VolitionRx Limited recovery probabilityLong Setup & Weekly Watchlist of Top Performers - Newser
Should I add VolitionRx Limited stock to my portfolioDollar Strength & Weekly Top Stock Performers List - sundaytimes.kr
Analyzing drawdowns of VolitionRx Limited with statistical tools2025 Geopolitical Influence & Low Risk High Win Rate Picks - Newser
Using data tools to time your VolitionRx Limited exitJuly 2025 Action & Weekly Watchlist for Hot Stocks - Newser
Is VolitionRx Limited stock entering bullish territoryMarket Sentiment Summary & High Conviction Buy Zone Picks - Newser
Analyzing VolitionRx Limited with risk reward ratio chartsBear Alert & Expert Curated Trade Setups - Newser
What risks could impact VolitionRx Limited stock performanceWeekly Stock Summary & Expert Approved Momentum Trade Ideas - Newser
Combining machine learning predictions for VolitionRx LimitedQuarterly Profit Report & Expert Approved Momentum Ideas - Newser
Applying big data sentiment scoring on VolitionRx LimitedMarket Growth Report & Fast Moving Stock Trade Plans - Newser
Key resistance and support levels for VolitionRx LimitedIndex Update & Safe Swing Trade Setup Alerts - Newser
Should you wait for a breakout in VolitionRx LimitedJuly 2025 Recap & Low Risk Growth Stock Ideas - Newser
Real time social sentiment graph for VolitionRx LimitedJuly 2025 Catalysts & Long-Term Capital Growth Strategies - Newser
VolitionRx Limited stock retracement – recovery analysisWeekly Trend Summary & Real-Time Stock Price Movement Reports - Newser
Has VolitionRx Limited found a price floor2025 Market Sentiment & Risk Managed Trade Strategies - Newser
Order flow analysis tools used on VolitionRx Limited2025 Market Outlook & Safe Entry Momentum Stock Tips - Newser
Comparing VolitionRx Limited in custom built stock radarsQuarterly Performance Summary & Fast Momentum Entry Tips - Newser
Can VolitionRx Limited rally from current levelsQuarterly Performance Summary & Verified Chart Pattern Trade Signals - Newser
VolitionRX Ltd Stock (VNRX) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.39%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):